scholarly journals Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours

2010 ◽  
Vol 46 (9) ◽  
pp. 1573-1579 ◽  
Author(s):  
Helen J. Mackay ◽  
Hal Hirte ◽  
Terrence Colgan ◽  
Al Covens ◽  
Katrina MacAlpine ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Platinum Resistant ◽  
Deacetylase Inhibitor ◽  
Ovarian Tumours

scholarly journals Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1281-1288 ◽  
Author(s):  
Missak Haigentz ◽  
Mimi Kim ◽  
Catherine Sarta ◽  
Juan Lin ◽  
Roger S. Keresztes ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Histone Deacetylase ◽  
Phase Ii ◽  
Neck Cancer ◽  
Histone Deacetylase Inhibitor ◽  
Phase Ii Trial ◽  
Deacetylase Inhibitor

A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5582-5582
Author(s):  
W. P. McGuire ◽  
H. W. Hirte ◽  
U. A. Matulonis ◽  
R. T. Penson ◽  
A. Husain ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Platinum Resistant

A phase II trial of weekly nab-paclitaxel with GM-CSF as chemoimmunotherapy for platinum-resistant epithelial ovarian cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 5020-5020
Author(s):  
R. E. Swensen ◽  
J. Childs ◽  
D. Higgins ◽  
T. Gooley ◽  
B. A. Goff ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Gm Csf ◽  
Platinum Resistant
Sign in / Sign up

Export Citation Format

Share Document